Skip to main content
Quest Diagnostics

Assessing Alzheimer's Disease Risk in Primary Care Settings

Assessing Alzheimer's Disease Risk in Primary Care Settings Through Blood-based Biomarkers

The objectives of this webinar include:

 

•  Discuss the rising prevalence of Alzheimer’s disease

 

•  Outline current challenges in assessing and monitoring Alzheimer’s disease

 

•  Illustrate the role of blood-based biomarkers in primary care settings

 

•  Explore emerging treatments and new diagnostic pathways

 

Date:
Jun 08, 2022
Location:
Virtual - LIVE Webinar
Presenter(s):
Dr Michael K. Racke & Dr Roberto Fernandez-Romero 
Moderator(s):
Gabriele Olla

Related content

On-Demand Webinar
Revolutionizing Alzheimer’s Disease Clinical Trials Using a Blood-Based Diagnostic Test for Participant Identification
On-Demand Webinar
The Emerging Role of Blood-based Biomarkers in Alzheimer's Disease
Audio Podcast
Alzheimer’s disease: A new generation of screenings and therapies on the horizon

Michael K. Racke, MD

Roberto Fernandez-Romero, MD, MPH, PhD

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.